Societal challenges and new treatments for Ebola virus disease

The Ebola virus, isolated in November 2014 from patient blood samples obtained in Mali. The virus was isolated on Vero cells in a BSL-4 suite at Rocky Mountain Laboratories. Credit: NIAID

Since Ebola was first described in 1976, there have been several outbreaks, but all have been self-limiting. In a new Journal of Internal Medicine review, Dr. Ali Mirazimi of the Karolinska Institutet considers why the latest outbreak occurred and discusses the factors that contributed to making it the largest, most sustained, and most widespread outbreak of Ebola.

He also notes that several potential treatments are now undergoing clinical trials and have shown initial promising results.

"Emerging and re-emerging infectious diseases will continue to challenge both human and animal health around the world," said Dr. Mirazimi.

"The Ebola virus, the emergence of new diseases like the Middle East Respiratory Syndrome (MERS) in the Arabic Peninsula, or the spread in Europe of some vector-borne infections such as those caused by the West Nile virus (WNV) are all examples.

Explore further

UN: Spread of MERS in South Korea isn't global emergency

More information: Mirazimi A (Karolinska Institutet, Stockholm; and National Veterinary Institute, Uppsala, Sweden). Ebola virus disease: societal challenges and new treatments. J Intern Med 2015; DOI: 10.1111/joim.12386
Journal information: Journal of Internal Medicine

Provided by Wiley
Citation: Societal challenges and new treatments for Ebola virus disease (2015, July 6) retrieved 25 May 2022 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors